324 filings
Page 5 of 17
8-K
4sq56 cvp
29 Sep 20
PolarityTE Announces Termination of Shareholder Rights Plan
8:00am
8-K
80gg sgaj7b
23 Sep 20
Other Events
8:00am
8-K
uqn7tg 6fc6y
16 Sep 20
SkinTE™ Health Economics—DFU Interim Analysis Data Demonstrates Potential for Cost Savings and Improved Wound Closure
8:00am
8-K
2hhsx3
14 Sep 20
Regulation FD Disclosure
8:00am
8-K
mzj9mz
8 Sep 20
PolarityTE Announces Strategic Partnership with Co-Diagnostics to Expand COVID-19 Testing Platform
8:30am
8-K
i8zp5
6 Aug 20
PolarityTE Reports Second Quarter 2020 Results
7:00am
8-K
v8koqcgzigxdqck
30 Jul 20
PolarityTE Announces the Addition of Clinical Development and Regulatory Affairs Executive Jessica Shen, MD, MS to Board of Directors
8:00am
8-K
chy8 orwnu5y
27 Jul 20
Regulation FD Disclosure
4:30pm
8-K
c4fld4xc8tfuwm0
24 Jul 20
PolarityTE Announces Positive Top-Line Data from Interim Analysis of SkinTE™ Diabetic Foot Ulcer Trial
8:00am
8-K
ylqi5i3g1xu6
22 May 20
Other Events
4:05pm
8-K
jjls2cs3x6mftv0v
30 Apr 20
PolarityTE Provides Update on Corporate Strategy and Regulatory Pathway for SkinTE
4:15pm
8-K
pcyo567 bf3
21 Apr 20
PolarityTE Provides Corporate Update Related to COVID-19 and Announces Preliminary First Quarter Results
8:00am
8-K
2ewzdou46fmrzs
15 Apr 20
Entry into a Material Definitive Agreement
8:00am
8-K
b7u5392ya8b7up
8 Apr 20
Other Events
8:30am
8-K
ty3wqoj8899stm951r2k
7 Apr 20
PolarityTE Announces the Addition of Audit Executive Chris Nolet to Board of Directors
8:00am
8-K
ttbpky52g 9igtzvw
1 Apr 20
PolarityTE Announces Appointment of David Seaburg as CEO and Restructuring of Executive Team
8:30am
8-K
djdwgcdktyuw8l5
27 Mar 20
Regulation FD Disclosure
8:00am
8-K
5q9u8hlf ai8h
25 Mar 20
Entry into a Material Definitive Agreement
8:17am
8-K
pr56uhxgk
12 Mar 20
PolarityTE Reports Fiscal Year 2019 Financial Results
8:00am
8-K
61wk1ac ikes
14 Feb 20
PolarityTE Announces Public Offering of Common Stock and Warrants
6:05am